Skip to main content
  • University of California, Los Angeles
Giving
Home
  • About
    • Easton Family
    • Faculty and Staff
    • Neuroscience High School Scholars Program
    • Contact Us
  • Patient Care
    • About Alzheimer’s Disease
    • About Non-Alzheimer Dementias
    • Alzheimer's Disease Treatments
    • Caregiver Support Groups
    • Find A Specialist
    • Memory Clinics
    • Resources
  • Research
    • Clinical Studies
    • Alzheimer's Disease Research Center
    • California Alzheimer's Disease Center
    • Research Labs
    • Brain Donation Program
  • Health Professionals
  • News and Events
    • News
    • Media Coverage
    • Newsletters
    • View All Upcoming Events
  • University of California, Los Angeles
Breadcrumb
  1. Home
  2. Media

Media

UCLA neurologist Dr. Timothy Chang was interviewed by ABC7 Eyewitness News about his team’s research using AI to identify people at risk of undiagnosed Alzheimer’s disease.

UCLA’s New AI Tool May Help Identify People at Risk of Undiagnosed Alzheimer’s

Dr. Timothy Chang, UCLA neurologist, explained how early diagnosis is critical for patient care and access to new therapies and that AI could help identify..

January 24, 2026
1 min read
image-neurons-amyloid-plaques

UCLA Develops New Alzheimer's Disease Therapeutic

Dr. Varghese John, Dr. Istvan Mody, and colleagues were highlighted in a UCLA article about their recent therapeutic development, targeting ...

August 13, 2024
1 min read
UCLA Easton Center partners with community groups to reach those who are underserved, under-researched.

A More Inclusive Framework for Alzheimer’s Disease

The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...

June 26, 2024
1 min read
imag- diversity active lifestyle

Healthy Body. Healthy Mind.

In the Summer Edition of Keiro Connect, Dr. Kevin Bickart discussed physical activity, including dancing, to improve brain health and prevent dementia ...

June 26, 2024
1 min read
Dr. Keith Vossel on Radio Sirius XM-10-10-2023

An In-Depth Interview on Various Neurodegenerative Diseases

Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...

October 10, 2023
1 min read
image-sundown-water

Sundowning Occurs in Patients with Alzheimer’s and Dementia

Dr. Keith Vossel was interviewed in a Forbes Health article about sundowning and the symptoms that patients with Alzheimer’s and dementia may experience ...

July 26, 2023
1 min read
imag- diversity active lifestyle

Late Life with Active Lifestyle Lowers the Risk of Dementia

Dr. Keith Vossel was quoted in a Healthline article about a study revealed a socially and mentally active lifestyle in late life ...

July 18, 2023
1 min read
image-doctor_workplace

New Released Information About the Additional Medicare Coverages for Leqembi

Dr. Keith Vossel was quoted in a Boston Globe’s STAT News article about physicians and patients showing interest in learning about the new Alzheimer’s drug...

July 17, 2023
1 min read
stethoscope and table on white background

Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug

Dr. Keith Vossel was quoted in a San Francisco Chronicle article about Lecanemab.......

July 07, 2023
1 min read
Dr. Keith Vossel interview on Fox News News-7-7-2023

Lecanemab, the New FDA-approved Alzheimer’s Drug – What to Know

Watch Dr. Keith Vossel’s live interview with Marla Tellez on July 7th, FOX 11 News LA about Lecanemab.......

July 07, 2023
1 min read
Dr. Keith Vossel interview on KCAL LA Morning News-7-7-2023

Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 2 of 2)

Watch Dr. Keith Vossel’s exclusive live interview with KCAL-LA Morning News, about the benefits of the treatment, possible side effects, and expected costs...

July 07, 2023
1 min read
Dr. Keith Vossel interview on KCAL LA Evening News-7-6-2023

Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 1 of 2)

Watch Dr. Keith Vossel’s exclusive live interview with KCAL-LA Evening News, about the benefits of the treatment, possible side effects, and expected costs...

July 06, 2023
1 min read
US Department of Health and Human Services - Food and Drug Administration (FDA)

What Families Can Expect with the New FDA-Approved Alzheimer’s Medication, Leqembi

Watch Dr. Keith Vossel’s exclusive live interview with KNBC-LA, NBC Channel 4 News, about the FDA’s fully approved Alzheimer’s drug, Lecanemab....

July 06, 2023
1 min read
img-FDA approved Leqembi

What’s Next for Leqembi After A Full Approval by the FDA

Listen to Dr. Keith Vossel’s exclusive interview with KNX News Radio, about the FDA’s full approval of the first-in-class Alzheimer’s drug, Lecanemab....

July 06, 2023
1 min read
image2-heavy alcohol intake may worsen cognitive decline in Alzheimer’s disease

Heavy Alcohol Intake May Worsen Cognitive Decline in Alzheimer’s Disease

Dr. Keith Vossel, Director of the Easton Center, commented on recent Alzheimer’s model research suggested long-term excessive intake of alcohol can...

June 19, 2023
1 min read

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page
Mary S. Easton Center for Alzheimer’s Research and Care

710 Westwood Plaza, Room C-224
Los Angeles, CA 90095-1769
Office: (310) 794-3665
Alice C. Rubin Integrated Memory Clinic: (310) 794-1195

  • Facebook
  • X-Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Emergency
  • Accessibility
  • UCLA Privacy Policy
  • UCLA Health Privacy Notice
  • Login
© 2026 UCLA Health